Report Detail

Pharma & Healthcare Global Pemetrexed Injection Market Growth 2022-2028

  • RnM4488437
  • |
  • 30 August, 2022
  • |
  • Global
  • |
  • 114 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

The global market for Pemetrexed Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Pemetrexed Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Pemetrexed Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Pemetrexed Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Pemetrexed Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Pemetrexed Injection players cover Eagle Pharmaceuticals, AuroMedics Pharma, Teva Pharmaceutical Industries, Taro Pharma and Seacross Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Pemetrexed Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Pemetrexed Injection market, with both quantitative and qualitative data, to help readers understand how the Pemetrexed Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the Pemetrexed Injection market and forecasts the market size by Type (0.5g Bottle and 0.2g Bottle,), by Application (Non Squamous Non-Small Cell Lung Cancer and Squamous Cell Non-Small Cell Lung Cancer.), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
0.5g Bottle
0.2g Bottle

Segmentation by application
Non Squamous Non-Small Cell Lung Cancer
Squamous Cell Non-Small Cell Lung Cancer

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Eagle Pharmaceuticals
AuroMedics Pharma
Teva Pharmaceutical Industries
Taro Pharma
Seacross Pharmaceuticals
Simcere Pharmaceutical Group
Qilu Pharmaceutical
Pfizer
Jiangsu Anda Pharmaceutical
Yangtze River Pharmaceutical Group
Hansoh Pharmaceutical Group Company南京制药厂
Nanjing Pharmaceutical Factory
DEYAO PHARMA
Vianex S.A.-Plant C
Hainan Jinrui Pharmaceutical

Chapter Introduction
Chapter 1: Scope of Pemetrexed Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Pemetrexed Injection market size (sales and revenue) and CAGR, Pemetrexed Injection market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pemetrexed Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pemetrexed Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pemetrexed Injection market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Eagle Pharmaceuticals, AuroMedics Pharma, Teva Pharmaceutical Industries, Taro Pharma, Seacross Pharmaceuticals, Simcere Pharmaceutical Group, Qilu Pharmaceutical, Pfizer and Jiangsu Anda Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Pemetrexed Injection Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Pemetrexed Injection by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Pemetrexed Injection by Country/Region, 2017, 2022 & 2028
  • 2.2 Pemetrexed Injection Segment by Type
    • 2.2.1 0.5g Bottle
    • 2.2.2 0.2g Bottle
  • 2.3 Pemetrexed Injection Sales by Type
    • 2.3.1 Global Pemetrexed Injection Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Pemetrexed Injection Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Pemetrexed Injection Sale Price by Type (2017-2022)
  • 2.4 Pemetrexed Injection Segment by Application
    • 2.4.1 Non Squamous Non-Small Cell Lung Cancer
    • 2.4.2 Squamous Cell Non-Small Cell Lung Cancer
  • 2.5 Pemetrexed Injection Sales by Application
    • 2.5.1 Global Pemetrexed Injection Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Pemetrexed Injection Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Pemetrexed Injection Sale Price by Application (2017-2022)

3 Global Pemetrexed Injection by Company

  • 3.1 Global Pemetrexed Injection Breakdown Data by Company
    • 3.1.1 Global Pemetrexed Injection Annual Sales by Company (2020-2022)
    • 3.1.2 Global Pemetrexed Injection Sales Market Share by Company (2020-2022)
  • 3.2 Global Pemetrexed Injection Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Pemetrexed Injection Revenue by Company (2020-2022)
    • 3.2.2 Global Pemetrexed Injection Revenue Market Share by Company (2020-2022)
  • 3.3 Global Pemetrexed Injection Sale Price by Company
  • 3.4 Key Manufacturers Pemetrexed Injection Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Pemetrexed Injection Product Location Distribution
    • 3.4.2 Players Pemetrexed Injection Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pemetrexed Injection by Geographic Region

  • 4.1 World Historic Pemetrexed Injection Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Pemetrexed Injection Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Pemetrexed Injection Annual Revenue by Geographic Region
  • 4.2 World Historic Pemetrexed Injection Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Pemetrexed Injection Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Pemetrexed Injection Annual Revenue by Country/Region
  • 4.3 Americas Pemetrexed Injection Sales Growth
  • 4.4 APAC Pemetrexed Injection Sales Growth
  • 4.5 Europe Pemetrexed Injection Sales Growth
  • 4.6 Middle East & Africa Pemetrexed Injection Sales Growth

5 Americas

  • 5.1 Americas Pemetrexed Injection Sales by Country
    • 5.1.1 Americas Pemetrexed Injection Sales by Country (2017-2022)
    • 5.1.2 Americas Pemetrexed Injection Revenue by Country (2017-2022)
  • 5.2 Americas Pemetrexed Injection Sales by Type
  • 5.3 Americas Pemetrexed Injection Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Pemetrexed Injection Sales by Region
    • 6.1.1 APAC Pemetrexed Injection Sales by Region (2017-2022)
    • 6.1.2 APAC Pemetrexed Injection Revenue by Region (2017-2022)
  • 6.2 APAC Pemetrexed Injection Sales by Type
  • 6.3 APAC Pemetrexed Injection Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Pemetrexed Injection by Country
    • 7.1.1 Europe Pemetrexed Injection Sales by Country (2017-2022)
    • 7.1.2 Europe Pemetrexed Injection Revenue by Country (2017-2022)
  • 7.2 Europe Pemetrexed Injection Sales by Type
  • 7.3 Europe Pemetrexed Injection Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Pemetrexed Injection by Country
    • 8.1.1 Middle East & Africa Pemetrexed Injection Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Pemetrexed Injection Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Pemetrexed Injection Sales by Type
  • 8.3 Middle East & Africa Pemetrexed Injection Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Pemetrexed Injection
  • 10.3 Manufacturing Process Analysis of Pemetrexed Injection
  • 10.4 Industry Chain Structure of Pemetrexed Injection

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Pemetrexed Injection Distributors
  • 11.3 Pemetrexed Injection Customer

12 World Forecast Review for Pemetrexed Injection by Geographic Region

  • 12.1 Global Pemetrexed Injection Market Size Forecast by Region
    • 12.1.1 Global Pemetrexed Injection Forecast by Region (2023-2028)
    • 12.1.2 Global Pemetrexed Injection Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Pemetrexed Injection Forecast by Type
  • 12.7 Global Pemetrexed Injection Forecast by Application

13 Key Players Analysis

  • 13.1 Eagle Pharmaceuticals
    • 13.1.1 Eagle Pharmaceuticals Company Information
    • 13.1.2 Eagle Pharmaceuticals Pemetrexed Injection Product Offered
    • 13.1.3 Eagle Pharmaceuticals Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Eagle Pharmaceuticals Main Business Overview
    • 13.1.5 Eagle Pharmaceuticals Latest Developments
  • 13.2 AuroMedics Pharma
    • 13.2.1 AuroMedics Pharma Company Information
    • 13.2.2 AuroMedics Pharma Pemetrexed Injection Product Offered
    • 13.2.3 AuroMedics Pharma Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 AuroMedics Pharma Main Business Overview
    • 13.2.5 AuroMedics Pharma Latest Developments
  • 13.3 Teva Pharmaceutical Industries
    • 13.3.1 Teva Pharmaceutical Industries Company Information
    • 13.3.2 Teva Pharmaceutical Industries Pemetrexed Injection Product Offered
    • 13.3.3 Teva Pharmaceutical Industries Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Teva Pharmaceutical Industries Main Business Overview
    • 13.3.5 Teva Pharmaceutical Industries Latest Developments
  • 13.4 Taro Pharma
    • 13.4.1 Taro Pharma Company Information
    • 13.4.2 Taro Pharma Pemetrexed Injection Product Offered
    • 13.4.3 Taro Pharma Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Taro Pharma Main Business Overview
    • 13.4.5 Taro Pharma Latest Developments
  • 13.5 Seacross Pharmaceuticals
    • 13.5.1 Seacross Pharmaceuticals Company Information
    • 13.5.2 Seacross Pharmaceuticals Pemetrexed Injection Product Offered
    • 13.5.3 Seacross Pharmaceuticals Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Seacross Pharmaceuticals Main Business Overview
    • 13.5.5 Seacross Pharmaceuticals Latest Developments
  • 13.6 Simcere Pharmaceutical Group
    • 13.6.1 Simcere Pharmaceutical Group Company Information
    • 13.6.2 Simcere Pharmaceutical Group Pemetrexed Injection Product Offered
    • 13.6.3 Simcere Pharmaceutical Group Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Simcere Pharmaceutical Group Main Business Overview
    • 13.6.5 Simcere Pharmaceutical Group Latest Developments
  • 13.7 Qilu Pharmaceutical
    • 13.7.1 Qilu Pharmaceutical Company Information
    • 13.7.2 Qilu Pharmaceutical Pemetrexed Injection Product Offered
    • 13.7.3 Qilu Pharmaceutical Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Qilu Pharmaceutical Main Business Overview
    • 13.7.5 Qilu Pharmaceutical Latest Developments
  • 13.8 Pfizer
    • 13.8.1 Pfizer Company Information
    • 13.8.2 Pfizer Pemetrexed Injection Product Offered
    • 13.8.3 Pfizer Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Pfizer Main Business Overview
    • 13.8.5 Pfizer Latest Developments
  • 13.9 Jiangsu Anda Pharmaceutical
    • 13.9.1 Jiangsu Anda Pharmaceutical Company Information
    • 13.9.2 Jiangsu Anda Pharmaceutical Pemetrexed Injection Product Offered
    • 13.9.3 Jiangsu Anda Pharmaceutical Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Jiangsu Anda Pharmaceutical Main Business Overview
    • 13.9.5 Jiangsu Anda Pharmaceutical Latest Developments
  • 13.10 Yangtze River Pharmaceutical Group
    • 13.10.1 Yangtze River Pharmaceutical Group Company Information
    • 13.10.2 Yangtze River Pharmaceutical Group Pemetrexed Injection Product Offered
    • 13.10.3 Yangtze River Pharmaceutical Group Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Yangtze River Pharmaceutical Group Main Business Overview
    • 13.10.5 Yangtze River Pharmaceutical Group Latest Developments
  • 13.11 Hansoh Pharmaceutical Group Company南京制药厂
    • 13.11.1 Hansoh Pharmaceutical Group Company南京制药厂 Company Information
    • 13.11.2 Hansoh Pharmaceutical Group Company南京制药厂 Pemetrexed Injection Product Offered
    • 13.11.3 Hansoh Pharmaceutical Group Company南京制药厂 Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Hansoh Pharmaceutical Group Company南京制药厂 Main Business Overview
    • 13.11.5 Hansoh Pharmaceutical Group Company南京制药厂 Latest Developments
  • 13.12 Nanjing Pharmaceutical Factory
    • 13.12.1 Nanjing Pharmaceutical Factory Company Information
    • 13.12.2 Nanjing Pharmaceutical Factory Pemetrexed Injection Product Offered
    • 13.12.3 Nanjing Pharmaceutical Factory Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Nanjing Pharmaceutical Factory Main Business Overview
    • 13.12.5 Nanjing Pharmaceutical Factory Latest Developments
  • 13.13 DEYAO PHARMA
    • 13.13.1 DEYAO PHARMA Company Information
    • 13.13.2 DEYAO PHARMA Pemetrexed Injection Product Offered
    • 13.13.3 DEYAO PHARMA Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 DEYAO PHARMA Main Business Overview
    • 13.13.5 DEYAO PHARMA Latest Developments
  • 13.14 Vianex S.A.-Plant C
    • 13.14.1 Vianex S.A.-Plant C Company Information
    • 13.14.2 Vianex S.A.-Plant C Pemetrexed Injection Product Offered
    • 13.14.3 Vianex S.A.-Plant C Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 Vianex S.A.-Plant C Main Business Overview
    • 13.14.5 Vianex S.A.-Plant C Latest Developments
  • 13.15 Hainan Jinrui Pharmaceutical
    • 13.15.1 Hainan Jinrui Pharmaceutical Company Information
    • 13.15.2 Hainan Jinrui Pharmaceutical Pemetrexed Injection Product Offered
    • 13.15.3 Hainan Jinrui Pharmaceutical Pemetrexed Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 Hainan Jinrui Pharmaceutical Main Business Overview
    • 13.15.5 Hainan Jinrui Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Pemetrexed Injection. Industry analysis & Market Report on Pemetrexed Injection is a syndicated market report, published as Global Pemetrexed Injection Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Pemetrexed Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,286.68
6,573.36
3,733.20
7,466.40
530,151.00
1,060,302.00
298,692.60
597,385.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report